Text Size
4734 studies found for:    vaccine

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities
Conditions: Immunizations;   Vaccination;   Influenza;   School Health
Interventions: Behavioral: School based flu vaccine: Low intensity;   Behavioral: School based flu vaccine: High intensity
22 Active, not recruiting Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus;   Biological: DTaP IPV//Hib vaccine;   Biological: Placebo;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal vaccine
23 Recruiting Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection
Condition: Vaccine Overdose of Undetermined Intent
Interventions: Biological: prophylactic peptide vaccine;   Biological: therapeutic peptide vaccine
24 Completed
Has Results 		Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)
Condition: Influenza
Interventions: Biological: Cell-Derived Trivalent Subunit Influenza Vaccine Lot 1 (cTIV);   Biological: Cell-Derived Trivalent Subunit Influenza Vaccine Lot 2 (cTIV);   Biological: Cell-Derived Trivalent Subunit Influenza Vaccine Lot 3 (cTIV);   Biological: Egg-Derived Trivalent Subunit Influenza Vaccine (TIV)
25 Completed A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants
Condition: Dengue
Interventions: Biological: Tetravalent live attenuated dengue vaccine;   Biological: Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine
26 Completed Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
Condition: FLU
Intervention: Biological: Influenza Trivalent Inactivated Vaccines
27 Recruiting Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine
Condition: Poliomyelitis
Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV);   Biological: Trivalent Oral Polio Vaccine (tOPV);   Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2);   Biological: Sanofi-Pasteur IPV (Sanofi IPV);   Biological: Glaxo SmithKline IPV (GSK IPV);   Biological: Serum Institute of India IPV (SII IPV)
28 Completed
Has Results 		Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.
Conditions: 13-valent Pneumococcal Vaccine;   Immunization;   Safety;   Antibody Response
Intervention: Biological: 13-valent pneumococcal conjugate vaccine
29 Completed
Has Results 		Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects
Condition: Pandemic Influenza Disease
Interventions: Biological: Placebo;   Biological: Trivalent influenza virus vaccine (TIV);   Biological: Adjuvanted monovalent influenza virus vaccine (aH5N1);   Biological: Adjuvanted trivalent influenza vaccine (aTIV)
30 Completed Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type B
Interventions: Biological: PENTAXIM™: DTacP IPV//PRP~T combined vaccine;   Biological: TETRAXIM™: DTacP IPV combined vaccine and ActHIB™: PRP tetanus conjugate vaccine
31 Terminated Influenza Vaccine Post Allogeneic Transplant
Conditions: Hematopoietic Stem Cell Transplant;   Hematologic Malignancy
Intervention: Biological: Influenza vaccine
32 Completed Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases
Condition: Influenza Disease
Intervention: Biological: Adjuvanted influenza vaccine
33 Active, not recruiting Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
Condition: H5N1 Influenza
Intervention: Biological: H5N1 Vaccine
34 Completed Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators
Condition: Patient Response to Fluzone ID Vaccine
Intervention:
35 Completed
Has Results 		Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.
Conditions: Meningococcal Infection;   Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine;   Haemophilus Influenza b Infections
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014);   Biological: PedvaxHIB;   Biological: Prevnar;   Biological: M-M-R II;   Biological: Varivax
36 Unknown † An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users
Conditions: Using Cocaine or Heroin in the Last 7 Days,;   Age Over 18 Years Old,;   Competent to Sign Informed Consent for HIV/HBV/HCV Testing,;   HIV/HBV Negatives Will be Randomized for HB Vaccine Study;   HIV Infections
Interventions: Biological: hepatitis B vaccine schedule;   Behavioral: HBV Vaccination Self-Efficacy Intervention
37 Completed Evaluating an Ebola and a Marburg Vaccine in Uganda
Conditions: Ebola Virus Disease;   Marburg Virus Disease
Interventions: Biological: Ebola vaccine;   Biological: Marburg vaccine;   Other: Placebo injection
38 Completed A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus;   Biological: OKAVAX®:Attenuated live varicella-zoster virus and AVAXIM® 80U: Hepatitis A virus Vaccines;   Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and Childhood vaccines;   Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and NaCl (Placebo)
39 Completed
Has Results 		Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)
Condition: Vaccine Response Impaired
Interventions: Biological: Tetanus & Diphtheria booster vaccine (Td);   Biological: TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine];   Biological: Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)
40 Completed
Has Results 		Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children
Conditions: Orthomyxoviridae Infection;   Influenza;   Myxovirus Infection
Interventions: Biological: Split, Inactivated, Trivalent Influenza Vaccine;   Biological: Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years